AuNPs for identification of molecular signatures of resistance

Frontiers in Microbiology

Volumn 5, Issue AUG, 2014, Pages

  Veigas, Bruno ^a   Fernandes, Alexandra R ^a   Baptista, Pedro V ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

AuNPs; Gold nanoparticles; Molecular diagnostics technologies; Multidrug resistance; Nanodiagnostics; Nanotechnology; Tuberculosis

Indexed keywords

GOLD NANOPARTICLE; MOLECULAR MARKER; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; DISEASE SURVEILLANCE; DNA SEQUENCE; ELECTRIC CONDUCTIVITY; GENE MUTATION; HUMAN; INFECTION CONTROL; MOLECULAR DIAGNOSTICS; MYCOBACTERIUM TUBERCULOSIS; NANOTECHNOLOGY; NONHUMAN; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

EID: 84987837082     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00455     Document Type: Review

References (72)

1. Abebe, G., Paasch, F., Apers, L., Rigouts, L., and Colebunders, R. (2011). Tuberculosis drug resistance testing by molecular methods: opportunities and challenges in resource limited settings. J. Microbiol. Methods 84, 155-160. doi: 10.1016/j.mimet.2010.11.014
2. Arbefeville, S. S., Zhang, K., Kroeger, J. S., Howard, W. J., Diekema, D. J., and Richter, S. S. (2011). Prevalence and genetic relatedness of methicillin-susceptible Staphylococcus aureus isolates detected by the Xpert MRSA nasal assay. J. Clin. Microbiol. 49, 2996-2999. doi: 10.1128/JCM.00046-11
3. Armstead, A. L., and Li, B. (2011). Nanomedicine as an emerging approach against intracellular pathogens. Int. J. Nanomed. 6, 3281-3293. doi: 10.2147/IJN.S27285
4. Aspler, A., Menzies, D., Oxlade, O., Banda, J., Mwenge, L., Godfrey-Faussett, P., et al. (2008). Cost of tuberculosis diagnosis and treatment from the patient perspective in Lusaka, Zambia. Int. J. Tuberc. Lung Dis. 12, 928-935.
5. Azzazy, H. M. E., and Mansour, M. M. H. (2009). In vitro diagnostic prospects of nanoparticles. Clin. Chim. Acta 403, 1-8. doi: 10.1016/j.cca.2009.01.016
6. Azzazy, H. M. E., Mansour, M. M. H., and Kazmierczak, S. C. (2006). Nanodiagnostics: a new frontier for clinical laboratory medicine. Clin. Chem. 52, 1238-1246. doi: 10.1373/clinchem.2006.066654
7. Azzazy, H. M. E., Mansour, M. M. H., and Kazmierczak, S. C. (2007). From diagnostics to therapy: prospects of quantum dots. Clin. Biochem. 40, 917-927. doi: 10.1016/j.clinbiochem.2007.05.018
8. Bailey, R. C., Nam, J. M., Mirkin, C. A., and Hupp, J. T. (2003). Real-time multicolor DNA detection with chemoresponsive diffraction gratings and nanoparticle probes. J. Am. Chem. Soc. 125, 13541-13547. doi: 10.1021/ja035479k
9. Baptista, P. V., Doria, G., Henriques, D., Pereira, E., and Franco, R. (2005). Colorimetric detection of eukaryotic gene expression with DNA-derivatized gold nanoparticles. J. Biotechnol. 119, 111-117. doi: 10.1016/j.jbiotec.2005.02.019
10. Baptista, P. V., Koziol-Montewka, M., Paluch-Oles, J., Doria, G., and Franco, R. (2006). Gold-nanoparticle-probe-based assay for rapid and direct detection of Mycobacterium tuberculosis DNA in clinical samples. Clin. Chem. 52, 1433-1434. doi: 10.1373/clinchem.2005.065391
11. Baptista, P. V., Pereira, E., Eaton, P., Doria, G., Miranda, A., Gomes, I., et al. (2008). Gold nanoparticles for the development of clinical diagnosis methods. Anal. Bioanal. Chem. 391, 943-950. doi: 10.1007/s00216-007-1768-z
12. Barnard, M., Albert, H., Coetzee, G., O'Brien, R., and Bosman, M. E. (2008). Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am. J. Respir. Crit. Care Med. 177, 787-792. doi: 10.1164/rccm.200709-1436OC
13. Bischof L. J., Lapsley, L., Fontecchio, K., Jacosalem, D., Young, C., Hankerd, R., et al. (2009). Comparison of chromogenic media to BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR for detection of MRSA in nasal swabs. J. Clin. Microbiol. 47, 2281-2283. doi: 10.1128/JCM.02256-08
14. Branton, D., Deamer, D. W., Marziali, A., Bayley, H., Benner, S. A., Butler, T., et al. (2008). The potential and challenges of nanopore sequencing. Nat. Biotechnol. 26, 1146-1153. doi: 10.1038/nbt.1495
15. Chadwick, S. G., Prasad, A., Smith, W. L., Mordechai, E., Adelson, M. E., and Gygax, S. E. (2013). Detection of epidemic USA300 community-associated methicillin-resistant Staphylococcus aureus strains by use of a single allele-specific PCR assay targeting a novel polymorphism of Staphylococcus aureus pbp3. J. Clin. Microbiol. 51, 2541-2550. doi: 10.1128/JCM.00417-13
16. Chan, W. S., Tang, B. S., Boost, M. V., Chow, C., and Leung, P. H. (2014). Detection of methicillin-resistant Staphylococcus aureus using a gold nanoparticle-based colourimetric polymerase chain reaction assay. Biosens. Bioelectron. 15, 105-111. doi: 10.1016/j.bios.2013.09.027
17. Chang, Y. C., Yang, C. Y., Sun, R. L., Cheng, Y. F., Kao, W. C., and Yang, P. C. (2013). Rapid single cell detection of Staphylococcus aureus by aptamer-conjugated gold nanoparticles. Sci. Rep. 3, 1863 doi: 10.1038/srep01863
18. Chastre, J., Blasi, F., Masterton, R. G., Rello, J., Torres, A., and Welte, T. (2014). European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clin. Microbiol. Infect. 4, 19-36. doi: 10.1111/1469-0691.12450
19. Chi, X., Huang, D., Zhao, Z., Zhou, Z., Yin, Z., and Gao, J. (2012). Nanoprobes for in vitro diagnostics of cancer and infectious diseases. Biomaterials 33, 189-206. doi: 10.1016/j.biomaterials.2011.09.032
20. Costa, M. N., Veigas, B., Jacob, J. M., Santos, D. S., Gomes, J., Baptista, P. V., et al. (2014). A low cost, safe, disposable, rapid and self-sustainable paper-based platform for diagnostic testing: lab-on-paper. Nanotechnology 25, 94006. doi: 10.1088/0957-4484/25/9/094006
21. Costa, P., Amaro, A., Botelho, A., Inácio, J., and Baptista, P. V. (2010). Gold nanoprobes assay for identification of mycobacteria from the Mycobacterium tuberculosis complex. Clin. Microbiol. Infect. 16, 1464-1469. doi: 10.1111/j.1469-0691.2010.03120.x
22. Das, M., Sumana, G., Nagarajan, R., and Malhotra, B. D. (2010). Application of nanostructured ZnO films for electrochemical DNA biosensor. Thin Solid Films 519, 1196-1201. doi: 10.1016/j.tsf.2010.08.069
23. Garner, P., Smith, H., Munro, S., and Volmink, J. (2007). Promoting adherence to tuberculosis treatment. Bull. World Health Organ. 85, 404-406. doi: 10.2471/BLT.06.035568
24. Gaspar, M. M., Cruz, A., Fraga, A. G., Castro, A. G., Cruz, M. E., and Pedrosa, J. (2008). Developments on drug delivery systems for the treatment of mycobacterial infections. Curr. Top. Med. Chem. 8, 579-591. doi: 10.2174/156802608783955629
25. Gill, P., and Ghaemi, A. (2008). Nucleic acid isothermal amplification technologies: a review. Nucleosides Nucleotides Nucleic Acids 27, 224-243. doi: 10.1080/15257770701845204
26. Halfpenny, K. C., and Wright, D. W. (2010). Nanoparticle detection of respiratory infection, Wiley Interdisciplinary Reviews. Nanomed. Nanobiotechnol. 2, 277-290. doi: 10.1002/wnan.83
27. Hartman, M. R., Ruiz, R. C., Hamada, S., Xu, C., Yancey, K. G., Yu, Y., et al. (2013). Point-of-care nucleic acid detection using nanotechnology Nanoscale 5, 10141-10154. doi: 10.1039/C3NR04015A
28. Hauck, T. S., Gao, S. G. Y., and Chan, W. C. W. (2010). Nanotechnology diagnostics for infectious diseases prevalent in developing countries. Adv. Drug Deliv. Rev. 62, 438-448. doi: 10.1016/j.addr.2009.11.015
29. Jain, K. K. (2005). Nanotechnology in clinical laboratory diagnostics. Clin. Chim. Acta 328, 37-54. doi: 10.1016/j.cccn.2005.03.014
30. Jain, K. K. (2007). Applications of nanobiotechnology in clinical diagnostics. Clin. Chem. 53, 2002-2009. doi: 10.1373/clinchem.2007.090795
31. Jeong, Y. J., Park, K., and Kim, D. E. (2009). Isothermal DNA amplification in vitro: the helicase-dependent amplification system. Cell. Mol. Life Sci. 66, 3325-3336. doi: 10.1007/s00018-009-0094-3
32. Johnson, C. J., Zhukovsky, N., Cass, A. E. G., and Nagy, J. M. (2007). Proteomics, nanotechnology and molecular diagnostics. Proteomics 8, 715-730. doi: 10.1002/pmic.200700665
33. Jung, Y. L., Jung, C., Parab, H., Li, T., and Park, H. G. (2010). Direct colorimetric diagnosis of pathogen infections by utilizing thiol-labeled PCR primers and unmodified gold nanoparticles. Biosens Bioelectron. 25, 1941-1946. doi: 10.1016/j.bios.2010.01.010
34. Kaittanis, C., Santra, S., and Perez, J. M. (2010). Emerging nanotechnology-based strategies for the identification of microbial pathogenesis. Adv. Drug Deliv. Rev. 62, 408-423. doi: 10.1016/j.addr.2009.11.013
35. Kelley, P. G., Grabsch, E. A., Farrell, J., Xie, S., Montgomery, J., Mayall, B., et al. (2011). Evaluation of the Xpert MRSA/SA Blood Culture assay for the detection of Staphylococcus aureus including strains with reduced vancomycin susceptibility from blood culture specimens. Diagn. Microbiol. Infect. Dis. 70, 404-407. doi: 10.1016/j.diagmicrobio.2011.02.006
36. Larguinho, M., and Baptista, P. V. (2012). Gold and silver nanoparticles for clinical diagnostics - from genomics to proteomics. J. Proteomics 75, 2811-2823. doi: 10.1016/j.jprot.2011.11.007
37. Lefferts, J. A., Schwab, M. C., Dandamudi, U. B., Lee, H. K., Lewis, L. D., and Tsongalis, G. J. (2010). Warfarin genotyping using three different platforms. Am. J. Transl. Res. 2, 441-446.
38. Liandris, E., Gazouli, M., Andreadou, M., Comor, M., Abazovic, N., Sechi, L. A., et al. (2009). Direct detection of unamplified DNA from pathogenic mycobacteria using DNA-derivatized gold nanoparticles. J. Microbiol. Methods 78, 260-264. doi: 10.1016/j.mimet.2009.06.009
39. Lin, C. C., Yang, Y. M., Liao, P. H., Chen, D. W., Lin, H. P., and Chang, H. C. (2014). A filter-like AuNPs-MS SERS substrate for Staphylococcus aureus detection. Biosens. Bioelectron. 53, 519-527. doi: 10.1016/j.bios.2013.10.017
40. Liu, W. T. (2006). Nanoparticles and their biological and environmental applications. J. Biosci. Bioeng. 102, 1-7. doi: 10.1263/jbb.102.1
41. Lixin, A., Tang, W., Ranalli, T. A., Kim, H. J., Wytiaz, J., and Kong, H. (2005). Characterization of a thermostable UvrD helicase and its participation in helicase-dependent amplification. J. Biol. Chem. 280, 28952-28958. doi: 10.1074/jbc.M503096200
42. Lizardi, P. M., Huang, X., Zhu, Z., Bray-Ward, P., Thomas, D. C., and Ward, D. C. (1998). Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat. Genet. 19, 225-232. doi: 10.1038/898
43. Maurice, C. B., Barua, P. K., Simses, D., Smith, P., Howe, J. G., and Stack, G. (2010). Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotyping. Clin. Chim. Acta 411, 947-954. doi: 10.1016/j.cca.2010.03.005
44. Mirkin, C. A., Letsinger, R. L., Mucic, R. C., and Storhoff, J. J. (1996). A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature 15, 607-609. doi: 10.1038/382607a0
45. Mothershed, E. A., and Whitney, A. M. (2005). Nucleic acid-based methods for the detection of bacterial pathogens: present and future considerations for the clinical laboratory. Clin. Chim. Acta 363, 206-220. doi: 10.1016/j.cccn.2005.05.050
46. Musser, J. M. (1995). Antimicrobial agent resistance in Mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8, 496-514.
47. Ngo, Y. H., Li, D., Simon, G. P., and Garnier, G. (2011). Paper surfaces functionalized by nanoparticles. Adv. Colloid Interface Sci. 163, 23-38. doi: 10.1016/j.cis.2011.01.004
48. Pedrosa, P., Veigas, B., Machado, D., Couto, I., Viveiros, M., and Baptista, P. V. (2014). Gold nanoprobes for multi loci assessment of multi-drug resistant tuberculosis. Tuberculosis 94, 332-337. doi: 10.1016/j.tube.2013.12.009
49. Pelgrift, R. Y., and Friedman, A. J. (2013). Nanotechnology as a therapeutic tool to combat microbial resistance. Adv. Drug Deliv. Rev. 65, 1803-1815. doi: 10.1016/j.addr.2013.07.011
50. Petryayeva, E., and Krull, U. J. (2011). Localized surface plasmon resonance: nanostructures, bioassays and biosensing-a review. Anal. Chim. Acta 706, 8-24. doi: 10.1016/j.aca.2011.08.020
51. Pissuwan, D., Cortie, C. H., Valenzuela, S. M., and Cortie, M. B. (2010). Functionalised gold nanoparticles for controlling pathogenic bacteria. Trends Biotechnol. 28, 207-213. doi: 10.1016/j.tibtech.2009.12.004
52. Pollock, N. R., McGray, S., Colby, D. J., Noubary, F., Nguyen, H., Nguyen, T. A., et al. (2013). Field evaluation of a prototype paper-based point-of-care fingerstick transaminase test. PLoS ONE 8:e75616. doi: 10.1371/journal.pone.0075616
53. Rosi, N. L., and Mirkin, C. A. (2005). Nanostructures in biodiagnostics. Chem. Rev. 105, 1547-1562. doi: 10.1021/cr030067f
54. Sato, K., Hosokawa, K., and Maeda, M. (2003). Rapid aggregation of gold nanoparticles induced by non-cross-linking DNA hybridization. J. Am. Chem. Soc. 125, 8102-8103. doi: 10.1021/ja034876s
55. Shinde, S. B., Fernandes, C. B., and Patravale, V. B. (2012). Recent trends in in-vitro nanodiagnostics for detection of pathogens. J. Control Release 159, 164-180. doi: 10.1016/j.jconrel.2011.11.033
56. Soini, H., and Musser, J. M. (2001). Molecular diagnosis of Mycobacteria. Clin. Chem. 47, 809-814.
57. Soo, P. C., Horng, Y. T., Chang, K. C., Wang, J. Y., Hsueh, P. R., Chuang, C. Y., et al. (2009). A simple gold nanoparticle probes assay for identification of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex from clinical specimens. Mol. Cell Probes 23, 240-246. doi: 10.1016/j.mcp.2009.04.006
58. Storhoff, J. J., Lucas, A. D., Garimella, V., Bao, Y. P., and Müller, U. R. (2004). Homogeneous detection of unamplified genomic DNA sequences based on colorimetric scatter of gold nanoparticle probes. Nat. Biotechnol. 22, 883-887. doi: 10.1038/nbt977
59. Tallury, P., Malhotra, A., Byrne, L. M., and Santra, S. (2009). Nanobioimaging and sensing of infectious diseases. Adv. Drug Deliv. Rev. 62, 424-437. doi: 10.1016/j.addr.2009.11.014
60. Tomita, N., Mori, Y., Kanda, H., and Notomi, T. (2008). Loop-mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products. Nat. Protoc. 3, 877-882. doi: 10.1038/nprot.2008.57
61. Torres-Chavolla, E., and Alocilja, E. C. (2011). Nanoparticle based DNA biosensor for tuberculosis detection using thermophilic helicase-dependent isothermal amplification. Biosens. Bioelectron. 26, 4614-4618. doi: 10.1016/j.bios.2011.04.055
62. Upadhyayula, V. K. (2012). Functionalized gold nanoparticle supported sensory mechanisms applied in detection of chemical and biological threat agents: a review. Anal. Chim. Acta 715, 1-18. doi: 10.1016/j.aca.2011.12.008
63. Van Deun, A., Aung, K. J., Bola, V., Lebeke, R., Hossain, M. A., de Rijk, W. B., et al. (2013). Rifampin drug resistance tests for tuberculosis: challenging the gold standard. J. Clin. Microbiol. 51, 2633-2640. doi: 10.1128/JCM.00553-13
64. Veigas, B., Doria, G., and Baptista, P. V. (2012a). Nanodiagnostics for Tuberculosis, Understanding Tuberculosis - Global Experiences and Innovative Approaches to the Diagnosis. Winchester: InTech, 562.
65. Veigas, B., Jacob, J. M., Costa, M. N., Santos, D. S., Viveiros, M., Inácio, J., et al. (2012b). Gold on paper-paper platform for Au-nanoprobe TB detection. Lab Chip 12, 4802-4808. doi: 10.1039/c2lc40739f
66. Veigas, B., Machado, D., Perdigão, J., Portugal, I., Couto, I., Viveiros, M., et al. (2010). Au-nanoprobes for detection of SNPs associated with antibiotic resistance in Mycobacterium tuberculosis. Nanotechnology 21, 5101-5108. doi: 10.1088/0957-4484/21/41/415101
67. Veigas, B., Pedrosa, P., Couto, I., Viveiros, M., and Baptista, P. V. (2013). Isothermal DNA amplification coupled to Au-nanoprobes for detection of mutations associated to Rifampicin resistance in Mycobacterium tuberculosis. J. Nanobiotechnol. 11, 1-6. doi: 10.1186/1477-3155-11-38
68. Wang S., Inci, E., Libero, G., Singhal, A., and Demirci, U. (2013). Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics. Biotechnol. Adv. 31, 438-449. doi: 10.1016/j.biotechadv.2013.01.006
69. Wilson M. L. (2011). Recent advances in the laboratory detection of Mycobacterium tuberculosis complex and drug resistance. Infect. Dis. 52, 1350-1355. doi: 10.1093/cid/cir146
70. World Health Organization [WHO]. (2012). Global Tuberculosis Report 2012. Geneva: WHO.
71. Xiang, Y., Deng, K., Xia, H., Yao, C., Chen, Q., Zhang, L., et al. (2013). Isothermal detection of multiple point mutations by a surface plasmon resonance biosensor with Au nanoparticles enhanced surface-anchored rolling circle amplification. Biosens. Bioelectron. 49, 442-449. doi: 10.1016/j.bios.2013.04.044
72. Yuan, L. Y., Li, Y., Wang, M., Ke, Z. Q., and Xu, W. Z. (2013). Rapid and effective diagnosis of pulmonary tuberculosis with novel and sensitive loop-mediated isothermal amplification (LAMP) assay in clinical samples: a meta-analysis. J. Infect. Chemother. 20, 86-92. doi: 10.1016/j.jiac.2013.07.003